• Info
  • Insider Ownership

Insider Trading & Ownership of Mohamad Makhzoumi

Location
Menlo Park, CA
Summary
The estimated net worth of Mohamad Makhzoumi is at least $411,105,088 dollars as of 11 Feb 2026. Mohamad Makhzoumi is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146.15M. Mohamad Makhzoumi is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $108.9M. Mohamad Makhzoumi is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.08M. Mohamad Makhzoumi is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.64M. Mohamad Makhzoumi is the 10%+ Owner of SpyGlass Pharma, Inc. and owns shares of SpyGlass Pharma, Inc. (SGP) stock worth about $37.77M. Mohamad Makhzoumi is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $16.81M. Mohamad Makhzoumi is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Mohamad Makhzoumi is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $318.1K. Mohamad Makhzoumi is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $78.3K. Mohamad Makhzoumi is the Director, 10%+ Owner of NeueHealth, Inc. and owns shares of NeueHealth, Inc. (NEUE) stock worth about $76.3K. Mohamad Makhzoumi is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $35.7K. Mohamad Makhzoumi is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $15.6K. Mohamad Makhzoumi is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $13.7K. Mohamad Makhzoumi is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. stock worth about $1.5K.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Mohamad Makhzoumi files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mohamad Makhzoumi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146,153,662 28 Jun 2021
SVRA Savara Inc 10%+ Owner $108,897,125 17 Jul 2023
KRRO Korro Bio, Inc. 10%+ Owner $61,084,408 22 Apr 2024
MBX MBX Biosciences, Inc. 10%+ Owner $38,638,855 16 Sep 2024
SGP SpyGlass Pharma, Inc. 10%+ Owner $37,772,629 09 Feb 2026
TRVI Trevi Therapeutics, Inc. 10%+ Owner $16,814,393 31 Dec 2025
MTCR Metacrine, Inc. 10%+ Owner $1,204,731 10 Dec 2021
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $318,142 13 Jun 2023
HOOD Robinhood Markets, Inc. Director $78,259 02 May 2022
NEUE NeueHealth, Inc. Director, 10%+ Owner $76,335 02 Oct 2025
IONQ, IONQ-WT IonQ, Inc. 10%+ Owner $35,689 16 Nov 2022
ACLX Arcellx, Inc. 10%+ Owner $15,641 20 Dec 2022
AVEO AVEO PHARMACEUTICALS, INC. 10%+ Owner $13,695 19 Oct 2022
DM Desktop Metal, Inc. 10%+ Owner $1,524 08 Jun 2021
AKUS Akouos, Inc. 10%+ Owner 30 Nov 2022
EAR Eargo, Inc. 10%+ Owner 24 May 2021
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner 24 May 2022

Insider Transactions Reported by Mohamad Makhzoumi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.